Telemus Capital, LLC Edwards Lifesciences Corp Transaction History

Telemus Capital, LLC

$1.2 Billion
Q4 2023

A detailed history of Telemus Capital, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Telemus Capital, LLC holds 7,872 shares of EW stock, worth $727,136. This represents 0.05% of its overall portfolio holdings.

Number of Shares

7,872

Previous 13,769 42.83%

Holding current value

$727,136

Previous $953,000 37.04%

% of portfolio

0.05%

Previous 0.09%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	SELL	$61.71 - $77.76 $363,903 - $458,550	-5,897 Reduced 42.83%	7,872 $600,000
Q3 2023 Oct 25, 2023	BUY	$69.28 - $93.38 $953,916 - $1.29 Million	13,769 New	13,769 $953,000
Q2 2023 Jul 10, 2023	BUY	$81.41 - $94.33 $213,131 - $246,955	2,618 Added 23.58%	13,720 $1.29 Million
Q1 2023 Apr 11, 2023	BUY	$74.26 - $84.51 $163,446 - $186,006	2,201 Added 24.73%	11,102 $918,000
Q4 2022 Jan 11, 2023	BUY	$68.3 - $87.44 $8,469 - $10,842	124 Added 1.41%	8,901 $0

Q3 2022 Oct 11, 2022	SELL	$82.37 - $107.29 $40,443 - $52,679	-491 Reduced 5.3%	8,777 $725,000
Q2 2022 Aug 10, 2022	BUY	$86.5 - $128.27 $33,908 - $50,281	392 Added 4.42%	9,268 $881,000
Q1 2022 Apr 06, 2022	BUY	$101.96 - $128.34 $293,236 - $369,105	2,876 Added 47.93%	8,876 $1.05 Million
Q4 2021 Feb 01, 2022	SELL	$106.37 - $130.68 $691,405 - $849,420	-6,500 Closed	0 $0
Q3 2021 Oct 27, 2021	BUY	$102.91 - $122.75 $668,915 - $797,875	6,500 New	6,500 $736,000
Q4 2020 Jan 28, 2021	SELL	$71.69 - $91.23 $1.15 Million - $1.46 Million	-16,000 Closed	0 $0
Q3 2020 Nov 02, 2020	SELL	$67.19 - $87.44 $335,950 - $437,200	-5,000 Reduced 23.81%	16,000 $1.37 Million
Q2 2020 Jul 17, 2020	BUY	$57.54 - $76.95 $805,560 - $1.08 Million	14,000 Added 200.0%	21,000 $1.42 Million
Q1 2020 Jun 05, 2020	SELL	$52.41 - $81.0 $366,870 - $567,000	-7,000 Closed	0 $0
Q4 2018 Feb 06, 2019	SELL	$46.41 - $56.94 $157,794 - $193,596	-3,400 Reduced 32.69%	7,000 $1.07 Million
Q3 2018 Oct 23, 2018	SELL	$45.7 - $58.03 $9,140 - $11,606	-200 Reduced 1.89%	10,400 $1.81 Million
Q2 2018 Jul 31, 2018	BUY	$42.45 - $51.3 $144,330 - $174,420	3,400 Added 47.22%	10,600 $1.54 Million
Q1 2018 Apr 27, 2018	SELL	$37.19 - $47.45 $5,243 - $6,690	-141 Reduced 1.92%	7,200 $1.01 Million
Q4 2017 Feb 02, 2018	BUY	$33.79 - $39.39 $3,210 - $3,742	95 Added 1.31%	7,341 $827,000
Q3 2017 Nov 03, 2017	SELL	$36.29 - $38.83 $4,245 - $4,543	-117 Reduced 1.59%	7,246 $792,000
Q2 2017 Apr 03, 2018	SELL	N/A	-7,000 Reduced 48.74%	7,363 $871,000
Q1 2017 Apr 03, 2018	BUY	N/A	14,363	14,363 $1.35 Million

Others Institutions Holding EW

# of Institutions

1,375

Shares Held

454M

Call Options Held

3.86M

Put Options Held

3.32M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $57.1B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Telemus Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Telemus Capital, LLC with notifications on news.

Account

Telemus Capital, LLC Edwards Lifesciences Corp Transaction History